39 completed, 8 unknown, 6 recruiting, 4 not yet recruiting. 65 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 65 | Completed 39, Unknown 8, Recruiting 6, Not yet recruiting 4, Withdrawn 4, Active not recruiting 1, Enrolling by invitation 1, Suspended 1, Terminated 1 |
Follow Hyperinsulinism: new trials by email Literature Review of Hyperinsulinism trials Research Report on Hyperinsulinism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peripheral Vascular Effects of Insulin in Obesity human insulin - Obesity (BMI>30), Insulin Resistance | Early Phase 1 | Not yet recruiting | University of Missouri-Columbia | 64 | 2026-12-01 | 2026-10-15 |
| Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity human insulin - Obesity (BMI>30), Insulin Resistance | Early Phase 1 | Not yet recruiting | University of Missouri-Columbia | 64 | 2026-12-01 | 2026-10-15 |
| Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome Indomethacin, Placebo, MRI - Metabolic Syndrome | Early Phase 1 | Not yet recruiting | University of Wisconsin, Madison | 72 | 2026-11-01 | 2026-11-02 |
| Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury Ischemic preconditioning, Intravenous lactate infusion, No ischemic preconditioning (control) - Metabolic Syndrome, Vascular Injury | Early Phase 1 | Not yet recruiting | Gary Van Guilder | 68 | 2026-10-01 | 2025-02-13 |
| Tirzepatide in Obesity-Driven Endometrial Cancer Tirzepatide - Endometrial Cancer, Obesity | Early Phase 1 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 20 | 2026-04-27 | 2026-10-02 |
| Insulin Intratympanic Application Insulin (Humulin), foam - Tympanic Membrane Perforation | Early Phase 1 | Completed | Deraya University | 50 | 2026-03-20 | 2026-09-04 |
| Crocus Sativus Tepals Water Extract in Obesity and Prediabetes Crocus sativus tepals cold aqueous extract, cold water - Prediabetes, Obesity & Overweight | Early Phase 1 | Recruiting | University of Primorska | 20 | 2026-02-06 | 2026-02-04 |
| Truway Diagnostic Tools in Primary Care Truway Portable Ultrasound Device, Truway Blood Glucose Monitor, Standard Oral Hypoglycemic Agent - Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight | Early Phase 1 | Enrolling by invitation | Truway Health, Inc. | 200 | 2025-10-01 | 2026-11-05 |
| Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes Study Visit 1, Placebo, Study Visit 2 - Type 1 Diabetes Mellitus, Glucokinase-Maturity Onset Diabetes of the Young (GCK-MODY) | Early Phase 1 | Recruiting | Vanderbilt University Medical Center | 27 | 2025-07-03 | 2025-12-23 |
| Akkermansia Muciniphilia and Metabolic Side Effects of ADT Apple Cider Vinegar - Prostate Cancer, Metabolic Syndrome | Early Phase 1 | Recruiting | Western University | 30 | 2025-07-02 | 2025-08-20 |
| Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity Hyperinsulinemic, euglycemic infusion - Insulin Resistance, Autonomic Dysfunction | Early Phase 1 | Withdrawn | University of Missouri-Columbia | 2024-02-01 | 2024-02-20 | |
| Time Restricted Eating in Sleep Apnea Time restricted eating - Time Restricted Eating, Obstructive Sleep Apnea | Early Phase 1 | Recruiting | University of California, San Diego | 80 | 2024-01-05 | 2024-01-16 |
| Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity GLY-LOW - Insulin Resistance, Obesity | Early Phase 1 | Completed | Hoskinson Health and Wellness Clinic | 13 | 2023-07-27 | 2025-06-10 |
| Glycemic Response of Whole Beans and Bean Products Alpha galactosidase, Placebo - Healthy, Body Mass Index, Normal | Early Phase 1 | Completed | Iowa State University | 21 | 2023-03-28 | 2024-10-08 |
| A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer. Pioglitazone - Metastatic Breast Cancer, Hyperinsulinism | Early Phase 1 | Recruiting | Rambam Health Care Campus | 30 | 2022-12-25 | 2023-03-03 |
| Nitrate Supplementation and Cerebrovascular and Cognitive Function in Metabolic Syndrome Beetroot Juice - Active, beetroot juice - Placebo - Metabolic Syndrome | Early Phase 1 | Completed | Penn State University | 22 | 2022-12-01 | 2025-05-06 |
| Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals Metyrapone 250 mg Oral Tablets, Placebo 250 mg Tablets, Hydrocortisone 19,9mg s.c., pulsatile with a flow rate of 10μl/s - Glucocorticoid Effect | Early Phase 1 | Completed | Eleonora Seelig | 20 | 2022-02-08 | 2023-08-23 |
| Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips Tetrahydrocannabivarin, Placebo - Metabolic Syndrome, Morbid Obesity | Early Phase 1 | Completed | Medical Life Care Planners, LLC | 56 | 2022-01-04 | 2022-10-10 |
| Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation Carbon dioxide breathing, Neurovascular Coupling, Human insulin - Healthy, Vasodilation | Early Phase 1 | Suspended | University of Missouri-Columbia | 65 | 2021-12-01 | 2025-12-19 |
| Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM REMD-477, Placebo Subcutaneous injection - Type 2 Diabetes, Glucose Tolerance Impaired | Early Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 4 | 2021-11-10 | 2024-08-09 |
Showing 20 of 65. Sign in to see all of them.
Insulin Resistance (42) · Metabolic Syndrome (21) · Obesity (17) · Diabetes Mellitus, Type 2 (10) · Cardiovascular Diseases (5) · Hyperlipidemias (5) · Hyperglycemia (4) · Diabetes Mellitus (3) · Diabetes Mellitus, Type 1 (3) · Overweight (3) · Prediabetic State (3) · Endometrial Neoplasms (2) · Glucose Intolerance (2) · Hypertension (2)
Glucose Metabolism Disorders (65) · Metabolic Diseases (65) · Nutritional and Metabolic Diseases (65) · Pathological Conditions, Signs and Symptoms (26) · Signs and Symptoms (23) · Body Weight (21) · Insulin Resistance (21) · Nutrition Disorders (21) · Overnutrition (20) · Endocrine System Diseases (18) · Overweight (17) · Diabetes Mellitus (12) · Neoplasms (9) · Neoplasms by Site (8)
Insulin (10) · Metformin (4) · Pioglitazone (3) · Sodium Chloride (3) · Glucose (2) · Saline Solution (2) · soybean oil, phospholipid emulsion (2) · 68Ga-NOTA-exendin-4 (1) · Acarbose (1) · Amino Acids (1) · Atropine (1) · Bed Rest (1) · Chenodeoxycholic Acid (1) · Cholecalciferol (1) · Cysteine (1)
University of Missouri-Columbia (5) · Lund University (4) · University of Virginia (3) · Catholic University of the Sacred Heart (2) · Pennington Biomedical Research Center (2) · Philip Kern (2) · The University of Texas Health Science Center at San Antonio (2) · University of Copenhagen (2) · Vanderbilt University Medical Center (2) · Ain Shams University (1) · AstraZeneca (1) · Boston University (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Deraya University (1) · Eleonora Seelig (1)
United States (36) · Sweden (6) · China (2) · Denmark (2) · Egypt (2) · Switzerland (2) · Canada (1) · Germany (1) · Israel (1) · Italy (1) · Slovakia (1) · Slovenia (1) · Spain (1) · United Kingdom (1)
Anne Nilsson, PhD (4) · Jacqueline K Limberg, Ph.D. (2) · Philip Kern, MD (2) · Ralph DeFronzo, MD (2) · Ayelet Shai, MD (1) · Bae-Jump Victoria, MD PhD (1) · Charles T. Roberts, PhD (1) · Daniel J Moore, MD, PhD (1) · Dhanesh Gupta, MD (1) · Eugene J Barrett, MD PhD (1) · Fang Li, MD (1) · Guang Ji, MD (1) · Jacqueline L Limberg, Ph.D. (1)
PMID 30089732, PMID 10857967, PMID 11522720, PMID 15078674, PMID 16681561, PMID 17896294, PMID 19064853, PMID 20082624, PMID 20970870, PMID 21324454, PMID 21813293, PMID 24265370, PMID 25013996, PMID 26259632, PMID 26990559, PMID 28431559, PMID 28531784, PMID 28594711, PMID 28803380, PMID 29106772, PMID 29338758, PMID 29781921, PMID 30353813, PMID 30459053, PMID 30992008, PMID 31158474, PMID 31415443, PMID 31821339, PMID 31875915, PMID 31961829, PMID 32598033, PMID 32977802, PMID 33433153, PMID 33481251, PMID 33571166, PMID 33908285, PMID 34043794, PMID 34090870, PMID 34560789, PMID 35142713, PMID 35405248, PMID 35438082, PMID 35578807, PMID 35894077, PMID 36171184, PMID 36947713, PMID 37486024, PMID 37565392, PMID 39882299
R01DK102359 (1), R01DK107646 (1), R01DK112282 (1), R01HL142250 (1), R01HL179276 (1), T32DK007646 (1), ZIAEB000073 (1)